Professional Documents
Culture Documents
Topic 1
General Orientation on Republic Act No. 9165
Dangerous Drugs classified as prohibited and regulated has thus far been an ever-continuing
plague that had swept through most countries throughout the world.
Reported recently by the concerned government agencies and published in newspapers, the
Philippines being one amongst the poorest countries in Asia, is the favorite transit point of illegal
drugs by foreign drug syndicates and local drug lords also. These powerful vultures have found their
way through the pockets of corrupt officials from the government and its local agencies. This is often
additionally to the very fact that our international sea and airport, lack trained personnel, system, and
gadgets in detecting the smuggling of these illegal drugs.
The situation had been advantageous to drug syndicate in making the cost of operation more cost-
effective. This is often another reason why they have chosen the Philippines as their drug’s trade.
Most types of drugs that circulate within the Philippines came from foreign sources except
marijuana which is already being grown in some forested and swampy areas within the country. There
are reported situations wherein government agents have penetrated some plantations within the
remote mountain province which led to the arrest of violators and thus the uprooting of these
marijuana plants. Variety of those plantations are being maintained by government leftist to induce
income and finance their illegal activities.
Most dangerous drugs are often from overseas sources and are commonly coming from
neighboring Asian countries like Taiwan, Hongkong, Korea, and Japan, while others are coming from
the United States of America.
For some who were not knowledgeable enough, most dangerous drugs charge an extremely
expensive price in the streets and had an overwhelming demand. With the ever-increasing demand for
these drugs, most of the enterprising drug dealers have become millionaires.
The reduction of illegal drugs in the country is difficult especially if we only depend on the
authorities. Since drug abuse and trafficking is a threat and danger to the society as a whole, each
citizen could take part and play an important role as a support in our government’s campaign against
these illegal activities.
At present, our authorities are blanketed with economic issues sided by graft and corruption
which has been the primary cause for our authorities’ inability to resolve our current drug situation.
Our country doesn’t have enough manpower and logistics to combat the issues head-on, and it's about
time that we, citizens give concern and get involved in the battle towards these threats to society for
the welfare of our very own families.
RA 9165 or Comprehensive Dangerous Drugs Act of 2002 approved on January 23, 2002, is also
known as “An Act Instituting The Comprehensive Dangerous Drug Act Of 2002, Repealing Republic
Act No. 6425, Otherwise Known As The Dangerous Drugs Act Of 1972, As Amended, Providing
NATIONAL SERVICE TRAINING PROGRAM 1 36
Module II: Drug Education
Funds Therefor, And For Other Purposes”. Is a consolidation of Senate Bill No. 1858 and House Bill
No. 4433, it was enacted and passed by the Senate of the Philippines and House of Representatives of
the Philippines on May 30, 2002 and May 29, 2002, respectively. It was signed into law by President
Gloria Macapagal-Arroyo on June 7, 2002.s
Comprehensive Dangerous Drugs Act of 2002 or Republic Act 9165 is an act that supersedes R A
6425 or the Dangerous Drugs Act of 1972. This amended law practices a more intensive approach
against drug abuse, trafficking and enforcement. It also gives emphasis on the role of the educational
system in information dissemination and prevention campaign. It re-evaluates the procedures, policies
and programs concerning drug abuse. It highlights the importance of rehabilitation and reintegration
of rehabilitated individuals to society
1. to safeguard the integrity of its territory & the well-being of its citizenry, particularly the
youth, from the harmful effects of dangerous drugs on their physical & mental well-being,
and
2. to defend the same against acts or omissions detrimental to their development and
preservation
3. to provide effective mechanisms or measures to re-integrate into society individuals who have
fallen victims to drug abuse or dangerous drug dependence through sustainable programs of
treatment and rehabilitation
Toward this end, the government shall pursue an intensive and unrelenting campaign against the
trafficking and use of dangerous drugs.
* Penalties range from six (6) months and one (1) day to life imprisonment and fines of ₱10,000.00 to
fifteen (15) million pesos depending on the person’s participation and sections of this law was
violated.
Section 12. Possession of Equipment, Apparatus and Other Paraphernalia for Dangerous
Drugs
Section 13. Possession of Dangerous Drugs During Parties, Social Gatherings or Meetings
Section 14. Possession of Equipment, Apparatus and Other Paraphernalia for Dangerous
Drugs During Parties, Social Gatherings or Meetings
Section 16. Cultivation or Culture of Plants Classified as Dangerous Drugs or Are Sources
Thereof
Section 20. Confiscation and Forfeiture of the Proceeds or Instruments of the Unlawful Act,
Including the Properties or Proceeds Derived from the Illegal Trafficking of
Dangerous Drugs and/or Controlled Precursors and Essential Chemicals
Section 21. Custody and Disposition of Confiscated, Seized and/or Surrendered Dangerous
Drugs, Plant Sources of Dangerous Drugs and/or Controlled Precursors and
Essential Chemicals, Instruments/ Paraphernalia and/or Laboratory
Equipment
Section 24. Non-Applicability of the Probation Law on Drug Traffickers and Pushers
Section 32. Liability of a Person Violating Any Regulation Issued by the Board
Section 86. Transfer, Absorption and Integration of All Operating Units on Illegal Drugs into
the PDEA and Transitory Provisions
NATIONAL SERVICE TRAINING PROGRAM 1 39
Module II: Drug Education
NATURE OF DRUGS
Drug defined
Drug means (1) articles recognized in the Official United States Pharmacopoeia, Official
Homeopathic Pharmacopoeia of the United States, or Official National Formulary, or any supplement
to them; and (2) articles intended for use in the diagnosis, cure4, mitigation, treatment, or prevention
of disease in man or other animals; and (3) articles (other than food) intended to affect the structure or
any function of the body of an or animals; and (4) articles intended for use as a component of any
articles specified in clauses (1), (2), or (3), but not include devices or their components, parts, or
accessories (Senate Bill No. 674, Section 5).
A substance used as a medication or in the preparation of medication that affects the body and
mind, and have potential for abuse. Without an advice or prescription from a physician, can be
harmful in such as to bring physiological, emotional or behavioral change. It may be legal (e.g.
alcohol, caffeine and tobacco) or illegal (e.g. cannabis, ecstasy, cocaine and heroin).
Includes those listed in the Schedules annexed to the 1961 Single Convention on Narcotic Drugs,
as amended by the 1972 Protocol and the Schedules annexed to the 1971 Single Convention on
Psychotropic Substances (R.A. No. 9165, Article I, Section 3). It also includes drugs, which are
hereinafter added to the list of dangerous drugs pursuant to Section 93 of R.A. No. 9165.
Dangerous drugs are those that have high tendency for abuse and dependency, these substances
may be organic, synthetic, and pose harm to those who use them.
Example:
Dangerous drugs refer to the broad categories or classes of controlled substances. Controlled
substances are generally grouped according to pharmacological classifications, effects and as to
their legal criteria.
A lot of people use the following stimulants every day: caffeine, nicotine and
ephedrine.
Stronger stimulant drugs include: amphetamines and methamphetamines, cocaine,
slimming tablets and dexamphetamine.
3. Hallucinogens – refers to the group of drugs that are considered to be mind altering
drugs, give the general effect of mood distortion and distorts the user’s perception of
reality.
This drugs include: LSD (lysergic acid diethylamide), magic mushroom (psilocybin),
mescaline (peyote mushroom), ecstasy (MDMA/methylenedioxymethamphetamine),
and ketamine.
B. According to Medical Pharmacology, dangerous drugs are classified as:
1. Depressants
2. Narcotics
3. Tranquilizers
4. Stimulants
5. Hallucinogens
6. Solvents/Inhalants
C. According to Legal Categories (in accordance to R.A. 6425). Pursuant to Republic Act
No. 6425, the Dangerous Drugs Act of 1972, the dangerous drugs are classified as:
1. Prohibited Drugs
a. Narcotics – refers to the group of drug opium and its derivatives, Morphine,
Heroin, Codeine, etc., including synthetic opiates
b. Stimulants – refers to the group of drug Cocaine, Alpha and Beta Eucaine, etc.
c. Hallucinogens – refers to the group of drugs like Marijuana, LSD (lysergic acid
diethylamide), mescaline, etc.
2. Regulated Drugs
a. Barbiturates – refers to the group of depressant drug known as “Veronal” like
Luminal, Amytal, Nembutal, Surital, Butisol, Penthonal, Seconal, etc.
b. Hypnotics – are group of drugs such as Mandrax, Quaalude, Fadormir, and
others.
c. Amphetamines – are group of stimulant drugs like Benzedrine, Dexedrine,
Methedrine, Preludin, etc.
3. Volatile Substances (P.D. 1619)
The group of liquid, solid or mixed substances having the property or releasing toxic
vapors or fumes which when sniffed, smelled, inhaled or introduced into the
physiological system of body produces or induces a condition of intoxication,
excitement or dulling of the brain or nervous system. Examples of these drugs are
Glue, Gasoline, Kerosene, Ether, Paint, Thinner, Lacquer, etc.
* NOTE: The passage of Republic Act 9165, Comprehensive Drug Law declassified the
above legal classification into one whole definition of dangerous drugs to include their
essential ingredients and precursors or chemical elements.
These are drugs which suppress vital body functions especially those in the brain or central
nervous system which resulting to impairment of judgment, hearing, speech and muscular
coordination.
In moderate doses, depressants can make you feel relaxed. Some depressants cause
euphoria and a sense of calm and well-being. They may be used to ‘wind down’ or to reduce
anxiety, stress or inhibition. Because they slow you down, depressants affects coordination,
concentration, and judgment, making driving and operating machinery hazardous.
In larger doses, depressants can cause unconsciousness by reducing breathing and heart
rate. A person’s speech may become slurred and their movements sluggish and uncoordinated.
Other effects of larger doses includes nausea, vomiting, and in extreme cases death. When taken
in combination, depressants increase their effects and increase the danger of overdose.
Depressant drugs include the narcotics, barbiturates, tranquilizers, alcohol and other volatile
solvents. These drugs, when taken in, generally decrease both the mental and physical activities
of the body. These drugs causes depression relieve pain and induce sedation or sleep and
suppress cough.
1. Narcotics – also called Opiates, re a group of drugs that are used medically to relieve pain,
and produce profound sleep or stupor when introduce to the body but have a high potential
for abuse. Medically, they are potent pain killers, cough depressants and as an active
component of anti-diarrhea preparations. Some opiates come from a resin taken from the
seedpod of the Asian poppy. Opiates that are commonly abused are Opium, Morphine,
Codeine, and synthesized or manufactured opiates as meperidine and methadone.
2. Opium - refers to the coagulated juice of the opium poppy (Papaver Somniferum L.) which
originates in Mesopotamia and embraces every kind, class and character of opium, whether
crude or prepared; the ashes or refuse of the same, narcotic preparations thereof or
therefrom; morphine or any alkaloid of opium; preparations in which opium, morphine or
any alkaloid of opium enters as an ingredient; opium poppy; poppy straw; and leaves or
wrappings of opium leaves, whether prepared for use or not. Popularly known as “gum”,
“gamut”, “kalamay” or “panocha”. Its active ingredient is the “meconic” acid – the
analgesic property.
3. Morphine – most commonly used and best used opiate. Effective as a pain killer six times
than opium, with a high dependence-producing potential. Morphine exerts action
characterized by analgesia, drowsiness, mood changes, and mental clouding.
4. Heroin – is three to five times more powerful than morphine from which it is derived and
the most addicting opium derivative. With continued use, addiction occurs within 14 days.
It may be sniffed, swallowed but is usually injected in the veins. Also known as “H”,
“hammer”, “smack”, “hell dust”, and “gear”.
5. Codeine – a derivative of morphine, commonly available in cough preparations. These
cough medicines have been widely abused by youth whenever hard narcotics are difficult to
obtain. Withdrawal symptoms are less severe than other drugs.
6. Paregoric – a tincture of opium in combination of camphor. Commonly used as a household
remedy for diarrhea and abdominal pain.
7. Demerol and Methadone – common synthetic drugs with morphine-like effects. Demerol is
widely used as a painkiller in childbirth while methadone is the drug of choice in the
withdrawal treatment of heroin dependents since it relieves the physical craving for heroin.
8. Barbiturates – are dugs used for inducing sleep in persons plagued with anxiety, mental
stress and insomnia. They are also of value in the treatment of epilepsy and hypertension.
They are available in capsules, pills or tablets, and taken orally or injected.
9. Seconal – commonly used among hospitality girls. Sudden withdrawal from these drugs is
even more dangerous than opiate withdrawal. The dependent develops generalized
convulsions and delirium, which are frequently associated with heart and respiratory failure.
10. Tranquilizers – are drugs used that calm and relax and diminish anxiety. They are used in
the treatment of nervous states and some mental disorders without producing sleep.
11. Volatile Solvents – gaseous substances popularly known to abusers as “gas”, “teardrops”.
Examples are plastic glues, hair spray, finger nail polish, lighter fluid, rugby, paint, thinner,
acetone, turpentine, gasoline, kerosene, varnishes and other aerosol products. They are
inhaled by the use of plastic bags, handkerchief of rags soaked in these chemicals.
12. Alcohol – the king of all drugs with potential for abuse. It is considered the most widely
used, socially accepted and most extensively legalized drug throughout the world.
They produce effects opposite to that of depressants. Instead of bringing about relaxation
and sleep, they produce increased mental alertness, wakefulness, reduce hunger, and provide a
feeling of wellbeing. Their medical users include narcolepsy – a condition characterized by an
overwhelming desire to sleep.
Stimulants speedup or stimulate the central nervous system and can make the users feel
more awake, alert and confident. Stimulants increase heart rate, body temperature and blood
pressure. Other physical effects include reduced appetite, dilated pupils, talkativeness, and sleep
disturbance.
Higher doses of stimulants can ‘over stimulate’ users, causing anxiety, panic, seizures,
headaches, stomach cramps, aggression, and paranoia. They can also cause heart problems such
as arrhythmia, prolonged or sustained use of strong stimulants can also cause these effects.
Strong stimulants can mask the effects of depressant drugs, such as alcohol. This can
increase the potential for aggression and poses an obvious for hazard. Abrupt withdrawal of the
drug from the heavy abuser can result in a deep and suicidal depression.
1. Amphetamine – drugs which speed up the messages travelling between the brain and the
body. Used medically for weight reducing in obesity, relief of mild depression. Some types of
amphetamines are legally prescribed by doctors to treat conditions such as attention deficit
hyperactivity disorder (ADHD) and narcolepsy (where a person has an uncontrollable urge to
sleep). Amphetamines have also been used to treat Parkinson’s disease. Other types of
amphetamines such as speed are produced and sold illegally.
2. Cocaine – the drug taken from coca bush plant (Erythroxylum Coca) grows in South America.
Also known as ‘coke’ or ‘snow’. It is usually in the form of powder that can be taken, orally,
injected or sniffed as to achieve euphoria or an intense feeling of “highness”.
3. Caffeine – it is present in coffee, tea, chocolate, cola drinks and some wake-up pills.
4. Methamphetamine – other names as ‘shabu’, ‘poor man’s cocaine’, ‘ice’, ‘crystal’, and
‘meth’. It is a central nervous system stimulant. It is white, colorless crystal or crystalline
powder with a bitter numbing taste, it can be taken orally, inhaled (snorted), sniffed (chasing
the dragon) or injected.
5. Nicotine – an addictive substance found in tobacco cigarettes and cigars which acts as a
powerful stimulant of the central nervous system. Nicotine is actually one of the most habit-
forming substances that exist. In fact, nicotine addiction is often compared to the intense
addictiveness associated with opiate like heroin. A drop a pure nicotine can easily kill a
person.
These are group of drugs that consists of a variety of mind-altering drugs, which distorts
reality, thinking and perceptions of time, sound, space and sensation. The user experiences
hallucination (false perception) which at times can be strange. His “trips” may be exhilarating
or terrifying good or bad. They may dislocate his consciousness and change his mood, thinking
and concept of self. There are many different kinds of psychedelics. Some occur naturally, in
trees, vines, seeds, fungi and leaves. Others are made in laboratories.
The effects of hallucinogens are not easy to predict and the person may behave in ways that
appear irrational or bizarre. Psychological effects often depends on the mood of the users and
the context of use. Negative effects may include panic, paranoia and loss of contact with reality.
In extreme cases, this can result in dangerous behaviour that can put the user and others at great
risk.
1. Marijuana – it is the most common abused hallucinogen in the Philippines because it can be
grown extensively in the country. Marijuana is the term used to describe all the plant material
like leaves, tops, stems, flowers and roots from a cannabis plant (Cannabis sativa), dried and
prepared for smoking or taken orally as “brownies”. Many users choose to smoke marijuana
for relaxation in the same way people drink beer or cocktail at the end of the day. The effects
of marijuana include a feeling of grandeur. It can also produce the opposite effect, a dreamy
sensation of time seeming to stretch out.
2. Lysergic Acid Diethylamide (LSD) – also known as ‘trips’, ‘acid’, and ‘microdots’. This drug
is the most powerful of the psychedelics obtained from ergot, a fungus that attacks rye
kernels. LSD is 1,000 times more powerful than marijuana as supply, large enough for a trip
can be taken from the glue on the flab of an envelope, from the hidden areas inside one’s
clothes. LSD causes perceptual changes so that the user sees color, shapes or objects more
intensely than normal and may have hallucinations of things that are not real. To him real
objects seem to change, building seems to be crackling open, and walls pulsating. He
experiences frequent bizarre hallucinations, loss spatial perceptions, personality diffusion and
changes in values. Usually users perceive distortion of time, colors, sounds and depth. They
experience “scent” music and sounds in “color”.
3. Peyote – derived from the surface from the surface part of a small gray brown cactus. Peyote
emits a nauseating odor and its users suffers from nausea. This drug causes no physical
dependence and therefore, no withdrawal symptoms; although in some cases psychological
dependence has been noted.
4. Mescaline – it is alkaloid hallucinogen extracted from the peyote cactus and can also be
synthesized in the laboratory. It produces less nausea than peyote and shows effects
resembling those of LSD although milder in nature. One to two hours after the drug is taken
in a liquid or powder form, delusions begin to occur. Optical hallucinations follow one upon
another in rapid succession. These are accompanied by imperfect coordination and perception
with a sensation of impeded motion, and a marked sense that time is still standing. Mescaline
does not cause physical dependence.
NATIONAL SERVICE TRAINING PROGRAM 1 44
Module II: Drug Education
5. Psilocybin – it is also called as magic mushrooms but more popularly known as “mushies” are
wild or cultivated mushrooms that contain psilocybin, a naturally-occurring psychoactive and
hallucinogenic compound. Psilocybin is considered one of the most well-known psychedelics,
according to the Substance Abuse and Mental Health Services Administrations. These
mushrooms induced nausea, muscular relaxation, mood changes with visions of bright colors
and shapes, and other hallucinations. These effects may last for four to five hours and later be
followed by depressions, laziness and complete loss of time and space perceptions.
6. Methylenedioxymethamphetamine (MDMA) – Commonly known as "Ecstasy", "X-TC",
"Adam", "Eden Tablet", or by its any other name - refers to the drug having such chemical
composition, including any of its isomers or derivatives in any form; "Ecstasy", the other
trendy drug, is the term used for a group of "designer" drugs closely related in chemical form
to the amphetamine family of illicit drugs. Methylenedioxymethamphetamine or MDMA is
the chemical name for "ecstasy" but it is also known as the yuppie drug, and the hug drug,
among others.
7. Ketamine – It is used by medical practitioners and veterinarians as an anaesthetic. It is
sometimes used illegally by people to get high. Ketamine can produce psychedelic effects,
causing a person to see, hear, smell, feel or taste things that aren’t really there or are different
from how they are in reality. When it’s sold illegally, ketamine usually comes as a white
crystalline powder. It can also be made into tablets and pills, or dissolved in a liquid. Also
known as ‘K’ and ‘Special K’.
COCAINE Short-term:
Narrowed blood vessels;
A powerfully addictive stimulant Enlarged pupils;
drug made from the leaves of the
Increased body temperature, heart
coca plant native to South
rate, and blood pressure;
America.
Headache;
Common Forms: White powder, Abdominal pain and nausea;
whitish rock crystal Euphoria;
Increased energy, alertness;
Common Ways Taken: Insomnia, restlessness;
Snorted, Anxiety;
Smoked, Erratic and violent behavior, panic attacks, paranoia, psychosis;
Injected Heart rhythm problems, heart attack;
Stroke, seizure, coma
Long-term:
Loss of sense of smell, nosebleeds, nasal damage and trouble
swallowing from snorting;
Infection and death of bowel tissue from decreased blood flow;
MARIJUANA Short-term:
Marijuana is made from the hemp Enhanced sensory perception and euphoria followed by
plant, Cannabis sativa. The main drowsiness/relaxation;
psychoactive (mind-altering)
Slowed reaction time;
chemical in marijuana is delta-9-
Problems with balance and coordination;
tetrahydrocannabinol, or THC.
Increased heart rate and appetite;
Common Forms: Greenish-gray Problems with learning and memory;
mixture of dried, shredded leaves, Anxiety.
stems, seeds, and/or flowers; resin
(hashish) or sticky, black liquid Long-term:
(hash oil) Mental health problems,
Chronic cough,
Common Ways Taken:
Frequent respiratory infections.
Smoked,
Vaped
Eaten (mixed in food or
brewed as tea)
METHAMPHETAMINE Short-term:
Lowered inhibition;
An extremely addictive stimulant Enhanced sensory perception;
amphetamine drug.
Increased heart rate and blood
Common Forms: White powder pressure;
or pill; crystal meth looks like Muscle tension; nausea;
pieces of glass or shiny blue- Faintness;
white "rocks" of different sizes Chills or sweating;
Sharp rise in body temperature leading to kidney failure or death.
Common Ways Taken:
Swallowed, Long-term:
Snorted, Long-lasting confusion, depression, problems with attention, memory,
and sleep;
Smoked,
Increased anxiety, impulsiveness;
Smoked,
Snorted,
Chewed,
Vaporized
DRUG MENACE
One of the problems that is severely affecting the Filipino youth and society today is drug
addiction. Many organizations, both public and private, have given this problem a prime concern.
However, as more means are pooled together to diminish, if not resolve this problem, reported cases
of drug dependents continue to soar.
A. BASIC CONCEPTS
a. DRUG ABUSE Defined
The term Drug Abuse most often refers to the use of a drug with such frequency
which may be detrimental to the user’s physical, emotional, intellectual, or spiritual well-
being. Others referred to this as “substance abuse”.
b. DRUG DEPENDENCY Defined
Drug abuse must be distinguished from drug dependence. Drug dependence is
sometimes called drug addiction, is defined by three (3) basic characteristics (Groiler,
1995).
1. The users continue to take a drug over an extended period of time.
2. The users find it difficult to stop using the drug. They seem powerless to quit the
drug use. Users take extraordinary and often harmful measures to continue using
the drug. They will drop out of school, steal, leave their families, go to jail and
lose their job just to keep using drug.
3. The users stop taking their drug – only if their supply of the drug is cut off, or
they are forced to quit for any reason – they will undergo painful physical or
mental distress. The experience of withdrawal syndrome, is a sure sign that a
drug is dependency-producing and the user is dependent on the drug. Drug
dependence may lead to drug abuse – especially the illegal drugs.
c. DRUG ADDICTION Defined
Drug addiction is a state of mind in which a person has lost the power of self-control
in respect of a drug. He consumes the drug repeatedly leaving aside all values of life. In
other words a drug addict will resort to crime even, to satisfy his repeated craving for the
drug. The effects of addiction are mainly deteriorative personality changers. They include
insomnia, instability, and lack of self-confidence especially when not under the influence
of drug. The addict cannot concentrate on any work. He avoids social contacts. Slowly,
mentally, physically, and morally he becomes bad to worse and a burden to the society
Characteristics of Drug Addiction
One or more of the following attributes characterizes drug addiction:
1. Uncontrollable Craving – the addict feels a compulsive craving to taker drug
repeatedly and tries to procure the same by any means.
2. Tolerance – it is the tendency to increase the dose of the drug to produce the
same effect as to that of the original effect.
3. Addiction – the addict is powerless to quit drug use.
4. Physical Dependence – the addict’s physiological functioning is altered. The
body becomes sick and incapable of carrying out useful activities in the
absence of the drug. The withdrawal syndromes will occur once the drug use
is stopped.
5. Withdrawal Syndrome – the addict becomes nervous and restless when he
does not get the drug. After about 12 hours, he starts sweating. His nose and
eyes become watery and continue doing so increasingly for another twelve
NATIONAL SERVICE TRAINING PROGRAM 1 48
Module II: Drug Education
ease symptoms. Non addictive medication and/or pain recovery services are often
available
4. Loneliness – Addiction can start when an individual feels lonely or is isolated from
the friends and family. They turn to drugs and alcohol thinking that it will fill a void
that they have been living with. People lacking positive daily interaction may choose
to use substances to feel happy or content. Additionally, users begin to alienate
themselves further if they fear being judged or that help is not available to them.
5. Peer Pressure – Peer pressure usually applies to adolescents or young adults. The
need to fit in, on some level, is built into each and every one of us. Some people may
feel the need to participate in potentially harmful activities to do so. The pressure of
being around others who are abusing drugs or alcohol can push someone to follow
suit.
6. Drugs And Alcohol Can Make You Feel Good – There is a popular quote in the Big
Book of Alcoholics Anonymous that states “Men and women drink essentially
because they like the effect produced by alcohol”. While this seems obvious, some
people like the effect so much that they are unable to stop. It may be difficult to see
the harm in something that makes you feel good.
7. Mental Health Disorder – Depression, anxiety, and PTSD can put individuals at
higher risk of developing an addiction. Using substances to cope with difficult
feelings may seem like an easier path for some. Though they may seem crippling at
times, there is help available to anyone struggling with a mental health disorder. Non-
narcotic medications are often available for most mental health disorders. It’s worth
researching with a doctor to see if there is an alternative to addictive medications.
8. Recreation – Many people use drugs or alcohol socially with friends or to “unwind”
after a long day. They often see substances as a way to relax or clear their minds.
Recreational drug users are still at risk to become addicted if their use becomes more
frequent or they use highly addictive substances.
9. Alcohol Isn’t Enough – For some, alcohol stops doing the trick. A few beers after
work or having drinks with friends at a local bar just doesn’t have the same effect that
it used to. Some individuals end up “chasing a buzz” that they were once able to
attain with a few drinks. This can leave someone powerless over alcohol and unable
to quit drinking.
10. Self-Medicating – People struggling with any of a multitude of ailments may turn to
drugs or alcohol to ease their pain. Mental health disorders and chronic pain leave
some seeking solutions on their own .Alcohol or other substances can alleviate
symptoms and seem like a short term solution. However, people should look for
manageable, long term solutions under medical supervision to combat these issues.
C. CLASSIFICATION OF DRUG ABUSERS
In order to understand the groups of people who abuse drugs, the group classification of
drug addicts are presented as:
1. Experimenters – people who abuse the drug(s) for experimental basis.
2. Occasional Users – abuse the drug occasionally/whenever there are special
occasions. They abuse the drug once every two (2) weeks to two (2) times a week.
3. Regular Users – abuse the drug on a regular basis approximately three (3) to four (4)
times a week or every other day.
4. Drug Dependents – people who tend to abuse the drug(s) everyday (almost every
day) or about five (5) to seven (7) times a week
Compulsion
Tolerance Relapse
Reduced social/occupational act
How To Stay Away From Drugs?
Devote yourself to your studies and other productive activities at home or in school
Stay away from people, places and events that promote drug use
Learn to manage feelings and cope with stress without using drugs
Develop a strong moral and spiritual foundation
Educate yourself about the effects of drug abuse
Always say NO
Counter-Measures for Substance Abuse
drug phenomena.
Based on PDEA’s intelligence and drug- related arrests,
methamphetamine hydrochloride, locally known as shabu, is the most
Cannabis or Marijuana
abused drug in the country, followed by cannabis or marijuana, and
methylenedioxy- methamphetamine (MDMA) or ecstasy.
During the first semester of the year, cocaine was recovered along
the Philippine shores by law enforcers and locals. However, there is no
conclusive indication that the cocaine was intended for local Methylenedioxymethamphetamine
consumption. (MDMA) or Ecstasy
into the country. There have been reports that this South American/Latino drug trafficking
organization is trying to break into the Philippine market due to the demand for methamphetamine, a
comparatively low- cost production, high-yielding, and high- profit drug as compared to the
neighboring Southeast Asian countries who prefer heroin and cocaine. Latest monitored activity of the
syndicate was in 2017 when 2.2 kilograms of shabu, sent from DHL Mexico, were recovered at DHL
Warehouse at NAIA.
In April 2018, the fourth drug syndicate that is monitored to be operating in the country is the
Golden Triangle drug syndicate, which was connected with the dismantled three clandestine
laboratories owned by the syndicate in Batangas and Malabon City. The syndicate is involved in
large-scale production of methamphetamine in Myanmar for distribution in the Asia Pacific region.
smallest political unit. As of December 2018, out of the total 42,045 barangays in the country, 22,041
or 52.42% are considered drug-affected.
c. Drug Cleared Barangay – classified as previously drug affected and subjected to drug
clearing operation and declared free from any illegal drug activities pursuant to the
parameters set forth by the regulation.
CONTROLLED SUBSTANCES
According to legal-dictionary.thefreedictionary.com, controlled substance is a drug which has
been declared by federal or state law to be illegal for sale or use, but may be dispensed under a
physician's prescription. The basis for control and regulation is the danger of addiction, abuse,
physical and mental harm (including death), the trafficking by illegal means, and the dangers from
actions of those who have used the substances.
LIST OF CONTROLLED SUBSTANCES
Some examples of substances listed in Schedule I are: heroin, lysergic acid diethylamide
(LSD), marijuana (cannabis), peyote, methaqualone, and 3,4-
methylenedioxymethamphetamine ("Ecstasy").
International non- Other non-proprietary
Chemical name
proprietary name (INN) or trivial name
BROLAMFETAMINE DOB (±)-4-bromo-2,5-dimethoxy-alpha-methylphenethylamine
CATHINONE (x)-(S)-2-aminopropiophenone
Not available DET 3-[2-(diethylamino)ethyl]indole
Not available DMA (±)-2,5-dimethoxy-alpha-methylphenethylamine
Not available DMHP 3-(1,2-dimethylheptyl)-7,8,9,10-tetrahydro-6,6,9-trimethyl-
6H-dibenzo[b,d]pyran-1-olo
Not available DMT 3-[2-(dimethylamino)ethyl]indole
Not available DOET (±)-4-ethyl-2,5-dimethoxy-alpha-phenethylamine
ETICYCLIDINE PCE N-ethyl-1-phenylcyclohexylamine
ETRYPTAMINE 3-(2-aminobutyl)indole
(+)-LYSERGIDE LSD, LSD-25 9,10-didehydro-N,N-diethyl-6-methylergoline-8beta-
carboxamide
Not available mescaline 3,4,5-trimethoxyphenethylamine
Not available methcathinone 2-(methylamino)-1-phenylpropan-1-one
4-methylaminorex (±)-cis-2-amino-4-methyl-5-phenyl-2-oxazoline
Not available MMDA 2-methoxy-alpha-methyl-4,5-
(methylenedioxy)phenethylamine
Not available N-ethyl MDA (±)-N-ethyl-alpha-methyl-3,4-
(methylenedioxy)phenethylamine
Not available N-hydroxy MDA (±)-N-[alpha-methyl-3,4-
(methylenedioxy)phenethyl]hydroxylamine
Not available parahexyl 3-hexyl-7,8,9,10-tetrahydro-6,6,9-trimethyl-6H-
dibenzo[b,d]pyran-1-ol
Not available PMA p-methoxy-alpha-methylphenethylamine
Not available psilocine, psilotsin 3-[2-(dimethylamino)ethyl] indol-4-ol
PSILOCYBINE 3-[2-(dimethylamino)ethyl]indol-4-yl dihydrogen phosphate
ROLICYCLIDINE PHP, PCPY 1-(1-phenylcyclohexyl)pyrrolidine
Not available STP, DOM 2,5-dimethoxy-alpha,4-dimethylphenethylamine
TENAMFETAMINE MDA alpha-methyl-3,4-(methylenedioxy)phenethylamine
Not available tetrahydrocannabinol, the following isomers and their sterochemical variants: 7,8,9,10-
tetrahydro-6,6,9-trimethyl-3-pentyl-6H-dibenzo[b,d] pyran-1-ol (9R,10aR)-8,9,10,10a-
tetrahydro-6,6,9-trimethyl-3-pentyl-6H-dibenzo[b,d]pyran-1-ol (6aR,9R,10aR)-
6a,9,10,10a-tetrahydro-6,6,9-trimethyl-3-pentyl- 6H-dibenzo[b,d]pyran-1-ol (6aR,10aR)-
6a,7,10,10a-tetrahydro-6,6,9-trimethyl-3-pentyl-6H- dibenzo[b,d]pyran -1- ol 6a,7,8,9-
tetrahydro-6,6,9-trimethyl-3-pentyl-6H-dibenzo[b,d] pyran-1-ol (6aR,10aR)-
6a,7,8,9,10,10a-hexahydro-6,6-dimethyl-9-methylene- 3-pentyl-6H- dibenzo[b,d]pyran-1-
ol
Not available TMA (±)-3,4,5-trimethoxy-alpha-methylphenethylamine
The salts of the substances listed in this Schedule whenever the existence of such salts is possible.
Substances in Schedule II
Substances in this schedule have a high potential for abuse which may lead to severe
psychological or physical dependence.
Examples of Schedule II narcotics include: hydromorphone (Dilaudid®), methadone
(Dolophine®), meperidine (Demerol®), oxycodone (OxyContin®, Percocet®), and fentanyl
(Sublimaze®, Duragesic®). Other Schedule II narcotics include: morphine, opium, codeine,
and hydrocodone.
Examples of Schedule IIN stimulants include: amphetamine (Dexedrine®, Adderall®),
methamphetamine (Desoxyn®), and methylphenidate (Ritalin®).
Other Schedule II substances include: amobarbital, glutethimide, and pentobarbital.
International non- Other non-proprietary or
Chemical name
proprietary name (INN) trivial name
AMFETAMINE amphetamine (±)-alpha-methylphenethylamine
DEXAMFETAMINE dexamphetamine (+)-alpha-methylphenethylamine
FENETYLLINE 7-[2-[(alpha-methylphenethyl)amino] ethyl]theophylline
Substances in Schedule IV
Substances in this schedule have a low potential for abuse relative to substances in
Schedule III.
Examples of Schedule IV substances include: alprazolam (Xanax®), carisoprodol
(Soma®), clonazepam (Klonopin®), clorazepate (Tranxene®), diazepam (Valium®),
lorazepam (Ativan®), midazolam (Versed®), temazepam (Restoril®), and triazolam
(Halcion®).
International non- Other non-proprietary
Chemical name
proprietary name (INN) or trivial name
ALLOBARBITAL 5,5-diallylbarbituric acid
ALPRAZOLAM 8-chloro-1-methyl-6-phenyl-4H-s-triazolo[4,3-a]
[1,4]benzodiazepine
AMFEPRAMONE diethylpropion 2-(diethylamino)propiophenone
AMINOREX 2-amino-5-phenyl-2-oxazoline
BARBITAL 5,5-diethylbarbituric acid
BENZFETAMINE benzphetamine N-benzyl-N,alpha-dimethylphenethylamine
BROMAZEPAM 7-bromo-1,3-dihydro-5-(2-pyridyl)-2H-1,4-benzodiazepin-2-
one
Not available butobarbital 5-butyl-5-ethylbarbituric acid
BROTIZOLAM 2-bromo-4-(o-chlorophenyl)-9-methyl-6H-thieno[3,2-f]-s-
triazolo[4,3-a][1,4]diazepine
CAMAZEPAM 7-chloro-1,3-dihydro-3-hydroxy-1-methyl-5-phenyl-2H-1,4
benzodiazepin-2-one dimethylcarbamate (ester)
CHLORDIAZEPOXIDE 7-chloro-2-(methylamino)-5-phenyl-3H-1,4-benzodiazepine-4-
oxide
CLOBAZAM 7-chloro-2-(methylamino)-5-phenyl-3H-1,4-benzodiazepine-4-
oxide
CLONAZEPAM 5-(o-chlorophenyl)-1,3-dihydro-7-nitro-2H-1,4-benzodiazepin-
2-one
CLORAZEPATE 7-chloro-2,3-dihydro-2-oxo-5-phenyl-1H-1,4-benzodiazepine-
3-carboxylic acid
CLOTIAZEPAM 5-(o-chlorophenyl)-7-ethyl-1,3-dihydro-1-methyl-2H-thieno
[2,3-e] -1,4-diazepin-2-one
CLOXAZOLAM 10-chloro-11b-(o-chlorophenyl)-2,3,7,11b-tetrahydro-oxazolo-
[3,2-d][1,4]benzodiazepin-6(5H)-one
DELORAZEPAM 7-chloro-5-(o-chlorophenyl)-1,3-dihydro-2H-1,4-
benzodiazepin-2-one
DIAZEPAM 7-chloro-1,3-dihydro-1-methyl-5-phenyl-2H-1,4-
benzodiazepin-2-one
ESTAZOLAM 8-chloro-6-phenyl-4H-s-triazolo[4,3-a][1,4]benzodiazepine
ETHCHLORVYNOL 1-chloro-3-ethyl-1-penten-4-yn-3-ol
ETHINAMATE 1-ethynylcyclohexanolcarbamate
ETHYL LOFLAZEPATE ethyl 7-chloro-5-(o-fluorophenyl)-2,3-dihydro-2-oxo-1H-1,4-
benzodiazepine-3-carboxylate
ETIL AMFETAMINE N-ethylampetamine N-ethyl-alpha-methylphenethylamine
FENCAMFAMIN N-ethyl-3-phenyl-2-norborananamine
FENPROPOREX (±)-3-[(alpha-methylphenylethyl)amino]propionitrile
FLUDIAZEPAM 7-chloro-5-(o-fluorophenyl)-1,3-dihydro-1-methyl-2H-1,4-
benzodiazepin-2-one
FLURAZEPAM 7-chloro-1-[2-(diethylamino)ethyl]-5-(o-fluorophenyl)-1,3-
dihydro-2H-1,4-benzodiazepin-2-one
HALAZEPAM -chloro-1,3-dihydro-5-phenyl-1-(2,2,2-trifluoroethyl)-2H-1,4-
benzodiazepin-2-one
HALOXAZOLAM 10-bromo-11b-(o-fluorophenyl)-2,3,7,11b-tetrahydrooxazolo
[3,2-d][1,4]benzodiazepin-6(5H)-one
KETAZOLAM 11-chloro-8,12b-dihydro-2,8-dimethyl-12b-phenyl-4H-
[1,3]oxazino[3,2-d][1,4]benzodiazepine-4,7(6H)-dione
LEFETAMINE SPA (x)-N,N-dimethyl-1,2-diphenylethylamine
LOPRAZOLAM 6-(o-chlorophenyl)-2,4-dihydro-2-[(4-methyl-1-piperazinyl)
methylene]-8-nitro-1H-imidazo[1,2-a][1,4]benzodiazepin-1-
one
LORAZEPAM 7-chloro-5-(o-chlorophenyl)-1,3-dihydro-3-hydroxy-2H-1,4-
benzodiazepin-2-one
LORMETAZEPAM 7-chloro-5-(o-chlorophenyl)-1,3-dihydro-3-hydroxy-1-methyl-
2H-1,4-benzodiazepin-2-one
MAZINDOL 5-(p-chlorophenyl)-2,5-dihydro-3H-imidazo[2,1-a]isoindol-5-ol
MEDAZEPAM 7-chloro-2,3-dihydro-1-methyl-5-phenyl-1H-1,4-
benzodiazepine
MEFENOREX N-(3-chloropropyl)-alpha-methylphenethylamine
MEPROBAMATE 2-methyl-2-propyl-1,3-propanedioldicarbamate
MESOCARB 3-(alpha-methylphenethyl)-N-(phenylcarbamoyl)sydnone
imine
METHYLPHENOBARBITAL 5-ethyl-1-methyl-5-phenylbarbituric acid
METHYPRYLON 3,3-diethyl-5-methyl-2,4-piperidine-dione
MIDAZOLAM 8-chloro-6-(o-fluorophenyl)-1-methyl-4H-imidazo[1,5-a]
[1,4]benzodiazepine
NIMETAZEPAM 1,3-dihydro-1-methyl-7-nitro-5-phenyl-2H-1,4-benzodiazepin-
2-one
NITRAZEPAM 1,3-dihydro-7-nitro-5-phenyl-2H-1,4-benzodiazepin-2-one
NORDAZEPAM 7-chloro-1,3-dihdyro-5-phenyl-2H-1,4-benzodiazepin-2-one
OXAZEPAM 7-chloro-1,3-dihydro-3-hydroxy-5-phenyl-2H-1,4-
benzodiazepin-2-one
OXAZOLAM 10-chloro-2,3,7,11b-tetrahydro-2-methyl-11b-phenyloxazolo
[3,2-d][1,4]benzodiazepin-6(5H)-one
PHENDIMETRAZINE (+)-(2S,3S)-3,4-dimethyl-2-phenylmorpholine
PHENOBARBITAL 5-ethyl-5-phenylbarbituric acid
PHENTERMINE alpha,alpha-dimethylphenethylamine
PINAZEPAM 7-chloro-1,3-dihydro-5-phenyl-1-(2-propynyl)-2H-1,4-
benzodiazepin-2-one
PIPRADROL 1,1-diphenyl-1-(2-piperidyl)-methanol
PRAZEPAM 7-chloro-1-(cyclopropylmethyl)-1,3-dihydro-5-phenyl-2H-1,4-
benzodiazepin-2-one
PYROVALERONE 4'-methyl-2-(1,-pyrrolidinyl)valerophenone
SECBUTABARBITAL 5-sec-butyl-5-ethylbarbituric acid
TEMAZEPAM -chloro-1,3-dihydro-3-hydroxy-1-methyl-5-phenyl-2H-1,4-
benzodiazepin-2-one
TETRAZEPAM 7-chloro-5-(1-cyclohexen-1-yl)-1,3-dihydro-1-methyl-2H-1,4-
benzodiazepin-2-one
TRIAZOLAM 8-chloro-6-(o-chlorophenyl)-1-methyl-4H-s-triazolo[4,3-a]
[1,4]benzodiazepine
VINYLBITAL 5-(1-methylbutyl)-5-vinylbarbituric acid
The salts of the substances listed in this Schedule whenever the existence of such salts is possible.
DDB Amending Board Regulation No.5 Dangerous Drugs March 16, 2005
Regulation Series of 2003, entitled Guidelines Board
No. 1, S. in the Implementation of
2005 “Operation: Private Eye”
DDB Rules on the Suspension of Dangerous Drugs July 19, 2005
Regulation Sentence of a First-time Minor Board
No. 2, S. Drug Offender
2005
DDB Inclusion of Ketamine in the List Dangerous Drugs July 19, 2005
Regulation of Dangerous Drugs and Amending Board
No. 3, S. Section 32-6(b) of Board
2005 Regulation No.3, Series 2003 and
in the List of Dangerous Drugs to
be Prescribed in a Single
Applicable Prescription by a
Licensed Practitioner
DDB Reclassifying Ephedrine and Dangerous Drugs July 19, 2005
Regulation Pseudophedrine as Dangerous Board
No. 4, S. Drugs
2005
DDB Inclusion of Thionyl Chloride in Dangerous Drugs July 19, 2005
Regulation the List of Controlled Precursors Board
No. 5, S. and Essential Chemicals
2005
DDB Guidelines in the Implementation Dangerous Drugs June 6, 2006
Regulation of the Aftercare Program for Board
No. 1, S. Recovering Drug Dependents
2006
DDB Regulation Governing the Dangerous Drugs June 6, 2006
Regulation Implementation of Section 57 Board
No. 2, S. (Probation and Community Service
2006 under the Voluntary Submission
Program) and Section 70
(Probation or Community Service
for a First-time Minor Offender in
Lieu of Imprisonment) of RA 9165
DDB Guidelines for the Drug Dangerous Drugs June 6, 2006
Regulation Proficiency Testing (PT) Program Board
No. 3, S. for Drug Testing Laboratories
2006 (DTLs)
DDB Amending Board Regulation No.5, Dangerous Drugs December 6, 2006
Regulation Series of 2003, Entitled Guidelines Board
No. 4, S. in the Implementation of
2006 Operation “Private Eye”
DDB Imposing Fines and other Dangerous Drugs December 6, 2006
Regulation Sanctions for Violations Board
No. 5, S. Committed on the Pertinent
2006 Provisions of Board Regulation
No.3, Series of 2003
DDB Prescribing the Procedures for Dangerous Drugs December 6, 2006
Regulation Appeal regarding the Board
No. 6, S. Implementation of Board
2006 Regulation No.3, Series of 2003
DDB Institutionalizing the Dangerous Drugs December 6, 2006
Regulation Dangerous Drugs Board Integrated Board
No. 7, S. Drug Abuse Data Information
2006 Network (DDB IDADIN)
DDB Guidelines on the Disposition of Dangerous Drugs March 20, 2007
Regulation Confiscated, Seized and/or Board
No. 1, S. Surrendered Dangerous Drugs,
Manufacture, Prescription,
Dispensing, and Sale of, and other
Lawful Acts in connection with,
any Dangerous Drugs, Controlled
Precursors and Essential
Chemicals and other Similar or
Analogous Substances”
DDB Amending Board Regulation No.2, Dangerous Drugs December 11, 2007
Regulation Series of 2003, entitled Board
No. 8, S. “Implementing Rules and
2007 Regulations Governing
Accreditation of Drug Testing
Laboratories in the Philippines”
DDB Amending Board Regulation No.1, Dangerous Drugs December 11, 2007
Regulation Series of 2004, entitled Board
No. 9, S. “Prescribing Drug Test Fee for
2007 Government-Owned and Private
Drug Testing Laboratories
Accredited by the Department of
Health”
DDB Uniform Drug Inventory and Dangerous Drugs December 11, 2007
Regulation Tracking System Board
No. 10, S.
2007
DDB Inclusion of Oripavine in the List Dangerous Drugs May 14, 2008
Regulation of Dangerous Drugs Board
No. 1, S.
2008
DDB Inclusion of Amineptine in the List Dangerous Drugs
Regulation of Dangerous Drugs Board
No. 2, S.
2008
DDB Amending Board Regulation No.1, Dangerous Drugs May 14, 2008
Regulation Series of 2007 entitled Board
No. 3, S. “Guidelines on the Disposition of
2008 Confiscated, Seized and/or
Surrendered Dangerous Drugs,
Plant Sources of Dangerous Drugs,
Controlled Precursors and
Essential Chemicals,
Instruments/Paraphernalia,
and/or Laboratory Equipment in
connection with Cases under
Investigation, Preliminary
Investigation or Reinvestigation
DDB Amending Board Regulation No.4, Dangerous Drugs October 2, 2008
Regulation Series of 2003 entitled Board
No. 4, S. “Implementing Rules and
2008 Regulations Governing
Accreditation of Drug Abuse
Treatment and Rehabilitation
Centers and Accreditation of
Center Personnel”
DDB Creating the Committee on Dangerous Drugs October 23, 2008
Regulation Appeals of the Board and Board
No. 5, S. Prescribing the Procedures in
2008 Making an Appeal
DDB Guidelines on the Transfer/Re- Dangerous Drugs November 13, 2008
Regulation assignment of Police Witnesses Board
No. 6, S.
2008
DDB Guidelines for the Rehabilitation Dangerous Drugs March 26, 2009
Regulation of First Time Offenders Under Board
No. 1, S. Section 15 of RA 9165 Who Are
2009 Not Drug Dependents
DDB Implementing Guidelines for the Dangerous Drugs April 21, 2009
Regulation Implementation of Board Board
No. 2, S. Regulation No. 6, Series of 2007,
2009 entitled Classifying Toluene-Based
Contact Cement Products Without
at Least Five Percent (5%) Mustard
Oil Content as Dangerous Drugs
DDB General Guidelines for the Dangerous Drugs June 3, 2009
Regulation Conduct of Random Drug Testing Board
No. 3, S. for Students of Secondary,
2009 Tertiary, Vocational and Technical
Schools, Amending Board
Regulation No.6, Series of 2003
DDB Amending Section 18 and 19, Dangerous Drugs October 13, 2009
Regulation Article III of Board Regulation Board
No. 4, S. No.3, Series of 2003, entitled
2009 "Comprehensive Guidelines on
Importation, Distribution,
Manufacture, Prescription,
Dispensing and Sale of, and Other
Lawful Acts in connection with,
any Dangerous Drugs, Controlled
Precursors and Essential
Chemicals and Other Similar or
Analogous Substances"
DDB Inclusion of N-Benzylpiperazine Dangerous Drugs November 12, 2009
Regulation (BZP) in the List of Dangerous Board
No. 5, S. Drugs
2009
DDB Inclusion of Nalbuphine Dangerous Drugs January 16, 2013
Regulation Hydrochloride in the List of Board
No. 1, S. Dangerous Drugs
2010
DDB Amending Board Regulation No. 1, Dangerous Drugs September 12,
Regulation Series 2002, entitled "Guidelines Board 2013
No. 1, S. on the Custody and Disposition of
2013 Seized Dangerous Drugs,
Controlled Precursors and
Essential Chemicals, and
Laboratory Equipment" and for
Other Purposes.
DDB Inclusion of Methylephedrine in Dangerous Drugs September 12,
Regulation the list of dangerous drugs. Board 2013
No. 2, S.
2013
DDB Comprehensive Amendments to Dangerous Drugs February 3, 2014
Regulation Board Regulation No. 3 s 2003, Board
No. 3, S. "Comprehensive Guidelines on
2013 importation, distribution,
manufacture, prescription,
dispensing and sale of, and other
lawful acts in connection with any
dangerous drugs, controlled
precursors and essential chemicals
and other similar or analogous
No. 11, S.
2016
DDB Amending Certain Sections of Dangerous Drugs February 14, 2017
Regulation Board Regulation No. 10, Series of Board
No. 1, S. 2007, Entitled: "Uniform Drug
2017 Inventory and Tracking System"
DDB Adopting the Civil Service Dangerous Drugs February 14, 2017
Regulation Commission Sanction of Dismissal Board
No. 2, S. at First Offense for Employees or
2017 Officials in the Public Sector Who
Are Tested And Found Positive for
Illegal Drugs in the Amendment of
Sanctions Under Section 2 of
Board Regulation No. 2, Series of
2004
DDB Strengthening the Implementation Dangerous Drugs February 14, 2017
Regulation of Barangay Drug Clearing Board
No. 3, S. Program
2017
Executive Creation of an Inter-Agency By President Rodrigo March 6, 2017
Order No. 15, Committee on Anti-Illegal Drugs R. Duterte
S. 2017 (Icad) and Anti-Illegal Drug Task
Force to Suppress the Drug
Problem in the Country
DDB Amending Section 1 of Board Dangerous Drugs January 24, 2018
Regulation Regulation No. 4, Series of 2005 Board
No. 1, S. "Reclassifying Ephedrine and
2018 Pseudoephedrine as Dangerous
Drugs" by including the Isomers
and Salts of Isomers of Ephedrine
and Pseudoephedrine and by
including further their
Halogenated and Alkylated forms
thereof and the Salts, Isomers,
and Salts of Isomers of these
forms as well as any material,
compound, mixture or preparation
containing the same, in the list of
Dangerous Drugs
DDB Balay Silangan - Guidelines for Dangerous Drugs January 24, 2018
Regulation Community Involvement in Board
No. 2, S. Reforming Drug Offenders into
2018 Self-sufficient and Law-abiding
Members of Society
DDB Amending Section 3 (2) of Board Dangerous Drugs February 23, 2018
Regulation Regulation No. 1, Series of 2014 Board
No. 3, S. and Creating the Committee on
2018 Reclassification, Addition or
Removal of any Drug/Substance
from the List of Dangerous
Drugs/Controlled Precursors and
Essential Chemicals
DDB Inclusion of 4-Methylethcathinone Dangerous Drugs April 4, 2018
Regulation (4-MEC) in the List of Dangerous Board
No. 4, S. Drugs
2018
DDB Inclusion of 5F-APINACA (5-F-AKB- Dangerous Drugs April 4, 2018
Regulation 48) in the List of Dangerous Drugs Board
No. 5, S.
2018
2019
DDB SK Step Up Guidelines in Dangerous Drugs June 27, 2019
Regulation Institutionalizing Uniform Board
No. 5, S. preventive Education
2019
DDB Protocol When Handling Children Dangerous Drugs June 27, 2019
Regulation Allegedly Involved in Dangerous Board
No. 6, S. Drugs
2019
DDB Consolidated Revised Rules Dangerous Drugs
Regulation Governing Access to Treatment Board
No. 7, S. and Rehabilitation Programs and
2019 Services
Topic 2
Role of the Youth on Drug Detection and Prevention
The role of the youth in the nation building is crucial. They are problem solvers, have a positive
influence in other young people and the nation, and are extremely ambitious. They have the ability to
create an identity for themselves and move the nation forward.
As drug abuse and addiction is prevalent in the younger generation. It is imperative that the youth
take part in its prevention and rehabilitation efforts. Youth groups or organizations can be a vehicle in
which their community can help alleviate or eradicate the possibility of drug abuse. Whether
individually or as a group, the youth is a good driving force that could shape the drug abuse
prevention initiative of the country.
Here are some ways the youth can step up in this endeavour:
1. Understand. Know the concept of reality of drug abuse. Having a grasp of the addiction
can help in avoiding it and watching out for others.
2. Listen. Open yourself in the knowledge of the experts and experiences of others that have
undergone the abuse. Hear the stories and lessons to the heart.
3. Share. Share your knowledge and network in aiding others towards being informed and
recognizing their role in drug prevention.
4. Encourage. Give your peers and family members a good push in the right direction,
whether its prevention or rehabilitation.
5. Support. Take part in activities beneficial in the drug abuse prevention initiative. Add
your presence in the growing force tackling this issues.
6. Organize. Great minds think alike. Having a mutual goal, it is more purposeful to
combine efforts and sources to create a bigger impact about the concern.
7. Inform. Approached appropriate government agencies regarding incidents and cases of
drug abuse.
S – teadfats personality
N – oble character
What is SK STEP-UP?
The SK STEP-UP is designed as a supervisory level preventive education training program aimed
at empowering the SK and barangay youth leaders to be Certified Anti-Drug Advocates cascading and
harmonizing the government’s drug demand reduction strategy down to the grassroots level.
The youth leaders of the community, specifically SK Chairpersons, its Councilors, selected Local
Youth Development Council members, and other equally qualified youth leaders who are at least 18
years old, but not more than 24 years of age, shall be responsible in the regular conduct of prevention
activities and organizing anti-drug events in their barangays, lead by example, and empower and
inspire their age groups to stay away from illegal drugs.
The SK STEP-UP has three phases namely: Youth Camp; Trainer’s Training for the Youth
Leaders; and Ground Implementation, Monitoring, and Evaluation.
Youth Camp
The Local Government Units (LGUs), through their Anti-Drug Abuse Councils (ADACs) shall
hold 2 to 3-day youth camp with local SK Federation Chairmen, Councilors, or selected youth leaders
as participants. Besides supervising the youth camp, PDEA shall provide the subject matter experts
(SMEs), camp program and mechanics. The LGU will be responsible for the logistical requirements
for the event.
During the camp, participants are expected to exchange ideas, cultural experiences, best practices,
talents, and related skills. They will be assessed by the program officials and coordinators based on
their competencies and leadership potential for them to be considered in the next phase.
Trainer’s Training for the Youth Leaders
In this phase, the LGUs, through their ADACs, are required to organize 3 to 5-day Trainer’s
Training of Youth Leaders for those participants who passed the competency requirement of Phase I.
The training modules include the SK STEP-UP Program’s Administration; Comprehensive Drug
Abuse Prevention Education (DAPE); Communication and Life Skills Development; Practical
Community Immersion; Basic Research and Development; and Formulation of Action Plans and
Implementation.
“Upon successful completion of the trainer’s training program, graduating participants will be
conferred the distinction as SK STEP-UP Certified Anti-Drug Advocates,” said Aquino.
Ground Implementation, Monitoring, and Evaluation
The new anti-drug advocates are expected to conduct the ground implementation of his/her action
plans for their respective barangays. They need to submit quarterly reports of barangay advocacies to
their ADACs, to monitor the functionality and operationalization of the program.
SK STEP-UP’s Concept of Implementation
PDEA, as the Chairman for the National Secretariat for the SK STEP-UP Program, shall
orchestrate, coordinate and oversee the successful implementation of the program, in collaboration
with the DDB, Department of the Interior and Local Government (DILG), National Youth
Commission (NYC), as members of the National Secretariat.
The program also requires participation from the Philippine National Police (PNP), Department of
Education (DepED), Department of Health (DOH), Commission on Higher Education (CHED),
Technical Education and Skills Development Authority (TESDA), Department of Social Welfare and
Development (DSWD), and Juvenile Justice and Welfare Council (JJWC), for technical, logistical,
security, intelligence, and other related assistance and support.
Funding
The primary source of funds shall be borne by the LGUs, in accordance with Section 51 of
Republic Act 9165, or “The Comprehensive Dangerous Drugs Act of 2002”, Section 16 of RA 7160,
or The Local Government Code, and DILG Joint Memorandum Circular No. 1 series of 2019. Private
corporations may also provide funding as part of their Corporate Social Responsibility (CSR).
Penalties
Failure on the part of concerned local executives and officials to perform their functions following
the provisions of Board Regulation No. 5, shall be ground for the filing of appropriate charges.
Likewise, the failure of the LGUs to appropriate a substantial portion of their Annual Budgets to
assist in the implementation of anti-drug advocacy programs in their communities shall be ground for
disapproval of their yearly budget.
“The youth is the voice of this nation. They have the energy and passion to help the government
solidify the future of our next generation. Let us give our young people the chance for their voices to
be heard,” the PDEA chief said.